AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics

<p dir="ltr">Protein damage by glycation, oxidation and nitration is a continuous process in the physiological system caused by reactive metabolites associated with dicarbonyl stress, oxidative stress and nitrative stress, respectively. The term AGEomics is defined as multiplexed qua...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Naila Rabbani (291722) (author)
منشور في: 2022
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513548302942208
author Naila Rabbani (291722)
author_facet Naila Rabbani (291722)
author_role author
dc.creator.none.fl_str_mv Naila Rabbani (291722)
dc.date.none.fl_str_mv 2022-04-21T06:00:00Z
dc.identifier.none.fl_str_mv 10.3390/ijms23094584
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/AGEomics_Biomarkers_and_Machine_Learning_Realizing_the_Potential_of_Protein_Glycation_in_Clinical_Diagnostics/29046074
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Medical biochemistry and metabolomics
Health sciences
Health services and systems
glycation
machine learning
AGEomics
autism
diabetes
arthritis
Alzheimer’s disease
Parkinson’s disease
dc.title.none.fl_str_mv AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Protein damage by glycation, oxidation and nitration is a continuous process in the physiological system caused by reactive metabolites associated with dicarbonyl stress, oxidative stress and nitrative stress, respectively. The term AGEomics is defined as multiplexed quantitation of spontaneous modification of proteins damage and other usually low-level modifications associated with a change of structure and function—for example, citrullination and transglutamination. The method of quantitation is stable isotopic dilution analysis liquid chromatography—tandem mass spectrometry (LC-MS/MS). This provides robust quantitation of normal and damaged or modified amino acids concurrently. AGEomics biomarkers have been used in diagnostic algorithms using machine learning methods. In this review, I describe the utility of AGEomics biomarkers and provide evidence why these are close to the phenotype of a condition or disease compared to other metabolites and metabolomic approaches and how to train and test algorithms for clinical diagnostic and screening applications with high accuracy, sensitivity and specificity using machine learning approaches.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Molecular Sciences<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/ijms23094584" target="_blank">https://dx.doi.org/10.3390/ijms23094584</a></p>
eu_rights_str_mv openAccess
id Manara2_f00e31d03dd5d75b7cec74e5176df7fb
identifier_str_mv 10.3390/ijms23094584
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29046074
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical DiagnosticsNaila Rabbani (291722)Biomedical and clinical sciencesMedical biochemistry and metabolomicsHealth sciencesHealth services and systemsglycationmachine learningAGEomicsautismdiabetesarthritisAlzheimer’s diseaseParkinson’s disease<p dir="ltr">Protein damage by glycation, oxidation and nitration is a continuous process in the physiological system caused by reactive metabolites associated with dicarbonyl stress, oxidative stress and nitrative stress, respectively. The term AGEomics is defined as multiplexed quantitation of spontaneous modification of proteins damage and other usually low-level modifications associated with a change of structure and function—for example, citrullination and transglutamination. The method of quantitation is stable isotopic dilution analysis liquid chromatography—tandem mass spectrometry (LC-MS/MS). This provides robust quantitation of normal and damaged or modified amino acids concurrently. AGEomics biomarkers have been used in diagnostic algorithms using machine learning methods. In this review, I describe the utility of AGEomics biomarkers and provide evidence why these are close to the phenotype of a condition or disease compared to other metabolites and metabolomic approaches and how to train and test algorithms for clinical diagnostic and screening applications with high accuracy, sensitivity and specificity using machine learning approaches.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Molecular Sciences<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/ijms23094584" target="_blank">https://dx.doi.org/10.3390/ijms23094584</a></p>2022-04-21T06:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/ijms23094584https://figshare.com/articles/journal_contribution/AGEomics_Biomarkers_and_Machine_Learning_Realizing_the_Potential_of_Protein_Glycation_in_Clinical_Diagnostics/29046074CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/290460742022-04-21T06:00:00Z
spellingShingle AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
Naila Rabbani (291722)
Biomedical and clinical sciences
Medical biochemistry and metabolomics
Health sciences
Health services and systems
glycation
machine learning
AGEomics
autism
diabetes
arthritis
Alzheimer’s disease
Parkinson’s disease
status_str publishedVersion
title AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
title_full AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
title_fullStr AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
title_full_unstemmed AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
title_short AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
title_sort AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
topic Biomedical and clinical sciences
Medical biochemistry and metabolomics
Health sciences
Health services and systems
glycation
machine learning
AGEomics
autism
diabetes
arthritis
Alzheimer’s disease
Parkinson’s disease